IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
recorded an EBITDA loss of THB 101 million, a decline of THB 247 million from Q2/2019, due to the following operating factors: 1. Realized share of loss from associated company OKEA at THB 88 million
slowdown, 4/11 which result in a decline in ad spending on print media. However, the Company has adjusted strategic and business model to cope with such effects. The Company views that Bangna assets are no
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Period Six-month Period Digital content In 2Q2024, the Company had services income from digital content of THB 52.08 million, decreased by THB 0.71 million or -1.35% YoY. This was due to the decline in
Central Retail Corporation Public Company Limited Management discussion and analysis /Page 1 Management Discussion and Analysis The Thai economy is expected to gradually recover in line with COVID-19
Management Discussion and Analysis For the 1st Quarter 2021 ended May 31, 2021 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated reviewed the
PowerPoint Presentation After You Public Company Limited Management Discussion & Analysis YE 2020 Management Discussion & Analysis Q4/2020 Gross Profit and Gross Profit Margin • The Company’s gross
THB 1,229.18 million decreased by 11.64% Net Profit amounted to THB 205.67 million decreased by 52.19% 2022 Financial Summary Financial performance of Advice IT Infinite Public Company Limited and its